Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 5th International Breast Cancer Symposium is a multidisciplinary meeting focused on advances in breast cancer diagnosis, treatment, surgery, and survivorship. The programme covers early breast cancer, antibody-drug conjugates, HER2-positive disease, modern surgical management, lobular breast cancer, and research collaboration. It brings together specialists and other breast cancer care professionals for evidence-based learning and multidisciplinary discussion.
The 5th International Breast Cancer Symposium is a specialized breast oncology meeting taking place on 25–26 September 2026 at Cleveland Clinic Abu Dhabi, United Arab Emirates. Organized by Lumina Organizers, the symposium brings together oncologists, radiation oncologists, surgical oncologists, gynecologists, radiologists, oncology nurses, geneticists, allied healthcare professionals, and emerging healthcare professionals involved in breast cancer care. The scientific programme focuses on major developments in breast oncology, including early breast cancer, antibody-drug conjugates, HER2-positive disease, modern surgical management, survivorship, lobular breast cancer, and research collaboration. Sessions examine recent drug approvals and clinical trial data, evolving targeted therapies, radiation and surgical de-escalation strategies, and approaches to improving long-term survivorship and patient support. The symposium provides a multidisciplinary platform for discussing evidence-based advances and emerging treatment strategies in breast cancer care. It also emphasizes clinical research, regional and international collaboration, and the integration of different specialties in improving patient outcomes.
Updates and recent advancements in adjuvant endocrine therapy for early-stage breast cancer.
The evolving role and application of CDK4/6 inhibitors in early breast cancer treatment.
Strategies and clinical criteria for radiation de-escalation in selected patients.
Collaborative approaches to improving early-stage breast cancer care.
Insights into the biology, imaging techniques, and ongoing clinical trials for lobular breast cancer.
Managing menopause, fertility preservation, and lifestyle factors in breast cancer survivors.
The growing importance of clinical trial participation and international partnerships in the UAE.
Exploring the efficacy and application of T-DXd in various HER2 expression levels.
Integrating Sacituzumab govitecan into routine clinical practice.
Emerging data and the development of next-generation antibody-drug conjugates shaping treatment pathways.
Historical context and recent breakthroughs in HER2-targeted therapies.
Current strategies and integrated medical and radiation oncology perspectives for managing brain metastases.
Progressive strategies for surgical de-escalation in the axilla.
Techniques and outcomes in modern oncoplastic breast surgery.
The role of precision surgery and surgical interventions following neoadjuvant therapy.
The symposium offers CME credits for eligible attendees. Participants must scan their name badge barcode onsite to claim their credits.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Standard | Standard | Sep 25, 2026 | USD 70 |
| Cleveland Clinic Abu Dhabi Caregivers | Caregivers | Sep 25, 2026 | Free |
| Students & Residents | Students / Residents | Sep 25, 2026 | Free |
